COVID-19 Impact on Abbott Laboratories Revenue and Operations (Medical Devices)

COVID-19 Impact on Abbott Laboratories Revenue and Operations (Medical Devices)



Abbott is a medical technology company which designs, develops, manufactures and markets a wide range of medical devices, diagnostics, nutritional and generic medicines products, headquartered in United States, with global manufacturing and sales reach. Abbotts product range includes Continuous Glucose Monitoring; Remote Heart-Failure Monitoring; Chronic-Pain Devices; Blood and Plasma Screening; Point-of-care Testing; Adult and Pediatric Nutrition and also serves in providing the solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery and other heart related diseases. It also provides biologic solutions for the dental markets. The report, COVID-19 Impact on Abbott Laboratories Revenue and Operations (Medical Devices) presents a deep dive analysis into how Abbott Laboratories is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Abbott Laboratories is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

- Abbott reported third-quarter worldwide sales increased 9.6% with diagnostic sales increased 38.8% and medical devices sales increased 3.4%.
- Molecular diagnostics saw 313.1% growth in its third quarter due to the launch of critical new tests for COVID-19: Abbotts laboratory-based molecular tests for COVID-19 on its m2000™ and Alinity™ m platforms. Rapid Diagnostics experienced a growth in sales by 83.2% because of the strong demand of the Abbott’s POC ID NOW COVID-19 molecular test. However, core laboratory diagnostics sales growth was negatively impacted by lower routine diagnostics testing volumes.
- Due to the negative business impact of COVID-19, both cardiovascular and neuromodulation businesses were negatively impacted by reduced procedure volumes due to the pandemic. However, diabetes care grew 25.9% in the third quarter of 2020.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Abbott Laboratories -
- It provides insights on Abbott Laboratoriess exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

- An overview of how Abbott Laboratories will be affected by the COVID-19 pandemic.


COVID-19 impact analysis on Abbott Laboratories - Key Findings
Abbott Laboratories. Key Facts
Geographic spread analysis - COVID-19 vs Abbott Laboratories. sales
The impact of COVID-19 on regional GDP per capita levels
Abbott Laboratories. exposure: revenues by region and market vs regional impact levels
Abbott Laboratories : revenue impact by region and market for 2020
Operational reactions from Abbott Laboratories? Indications from recruitment trends
Operational reactions from Abbotts’ Indications from US pricing trends
Contact us


Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available